|
Avery, E.G., Bartolomaeus, H., Maifeld, A., Marko, L., Wiig, H., Wilck, N., Rosshart, S.P., Forslund, S.K.,Muller, D.N., 2021. The gut microbiome in hypertension recent advances and future perspectives. Circ. Res. 128, 934-950.
|
|
Barbadoro, P., Ponzio, E., Coccia, E., Prospero, E., Santarelli, A., Rappelli, G.G.L.,D'Errico, M.M., 2021. Association between hypertension, oral microbiome and salivary nitric oxide: a case-control study. Nitric Oxide 106, 66-71.
|
|
Blekkenhorst, L.C., Lewis, J.R., Prince, R.L., Devine, A., Bondonno, N.P., Bondonno, C.P., Wood, L.G., Puddey, I.B., Ward, N.C., Croft, K.D., et al., 2018. Nitrate-rich vegetables do not lower blood pressure in individuals with mildly elevated blood pressure: a 4-wk randomized controlled crossover trial. Am. J. Clin. Nutr. 107, 894-908.
|
|
Bondonno, C.P., Croft, K.D.,Hodgson, J.M., 2016. Dietary nitrate, nitric oxide, and cardiovascular health. Crit Rev Food Sci 56, 2036-2052.
|
|
Chen, H.R., Li, Q.W., Li, M., Liu, S., Yao, C.S., Wang, Z.X., Zhao, Z.Y., Liu, P., Yang, F., Li, X.J., et al., 2021. Microbial characteristics across different tongue coating types in a healthy population. J. Oral Microbiol. 13, 1946316.
|
|
Gao, L., Xu, T.S., Huang, G., Jiang, S., Gu, Y.,Chen, F., 2018. Oral microbiomes: more and more importance in oral cavity and whole body. Protein Cell 9, 488-500.
|
|
Hyde, E.R., Andrade, F., Vaksman, Z., Parthasarathy, K., Jiang, H., Parthasarathy, D.K., Torregrossa, A.C., Tribble, G., Kaplan, H.B., Petrosino, J.F., et al., 2014. Metagenomic analysis of nitrate-reducing bacteria in the oral cavity: implications for nitric oxide homeostasis. PLoS One 9(3): e8865.
|
|
Irfan, M., Delgado, R.Z.R.,Frias-Lopez, J., 2020. The oral microbiome and cancer. Front. Immunol. 11: 591088.
|
|
Kapil, V., Khambata, R.S., Robertson, A., Caulfield, M.J.,Ahluwalia, A., 2015. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients A randomized, phase 2, double-blind, placebo-controlled study. Hypertension 65, 320-327.
|
|
Kleinstein, S.E., Nelson, K.E.,Freire, M., 2020. Inflammatory networks linking oral microbiome with systemic health and disease. J. Dent. Res. 99, 1131-1139.
|
|
LaMonte, M.J., Gordon, J.H., Diaz-Moreno, P., Andrews, C.A., Shimbo, D., Hovey, K.M., Buck, M.J.,Wactawski-Wende, J., 2022. Oral microbiome is associated with incident hypertension among postmenopausal women. J. Am. Heart Assoc. 11: e021930.
|
|
Lupo, G.F.D., Rocchetti, G., Lucini, L., Lorusso, L., Manara, E., Bertelli, M., Puglisi, E.,Capelli, E., 2021. Potential role of microbiome in chronic fatigue syndrome/myalgic encephalomyelits (CFS/ME). Sci Rep-Uk 11: 7043.
|
|
Sato-Suzuki, Y., Washio, J., Wicaksono, D.P., Sato, T., Fukumoto, S.,Takahashi, N., 2020. Nitrite-producing oral microbiome in adults and children. Sci Rep-Uk 10: 16652.
|
|
Vanhatalo, A., Blackwell, J.R., L'Heureux, J.E., Williams, D.W., Smith, A., van der Giezen, M., Winyard, P.G., Kelly, J.,Jones, A.M., 2018. Nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood pressure in humans. Free Radical Biol. Med. 124, 21-30.
|
|
Wang, T.W., Yu, L., Xu, C., Pan, K.L., Mo, M.L., Duan, M.X., Zhang, Y.,Xiong, H.Y., 2018. Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function. PLoS One 13(9): e0203503.
|
|
Wang, Z.N., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X.M., Chung, Y.M., et al., 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63.
|
|
Willis, J.R.,Gabaldon, T., 2020. The human oral microbiome in health and disease: from sequences to ecosystems. Microorganisms 8(2), 308.
|
|
Yan, Y.X., Liu, Y.Q., Li, M., Hu, P.F., Guo, A.M., Yang, X.H., Qiu, J.J., Yang, S.S., Shen, J., Zhang, L.P., et al., 2009. Development and evaluation of a questionnaire for measuring suboptimal health status in urban Chinese. J. Epidemiol. 19, 333-341.
|
|
Zhang, L., Wang, Y.A., Li, Y., Li, L.L., Xu, S.W., Feng, X.J.,Liu, S., 2018. Hydrogen sulfide (H2S)-Releasing compounds: therapeutic potential in cardiovascular diseases. Front. Pharmacol. 9: 1066.
|
|
Zheng, W.W., Zhang, Z., Liu, C.H., Qiao, Y.Y., Zhou, D.R., Qu, J., An, H.J., Xiong, M., Zhu, Z.M.,Zhao, X.H., 2015. Metagenomic sequencing reveals altered metabolic pathways in the oral microbiota of sailors during a long sea voyage. Sci Rep-Uk 5: 9131.
|